Jayram G, Shore ND, Tyson M, Pieczonka C, et al. PD09-07 Durvalumab in Combination with Bacillus Calmette-Guerin for Bacillus Calmette-Guerin-Naive, High-Risk Non-Muscle-Invasive Bladder Cancer: Primary Results from a US-Based, Phase IIIB, Open-Label, Single-Arm, Multicenter Study (PATAPSCO): Erratu J Urol 2026;216:606.
PMID: 42713894